Who owns Cue Biopharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of CUE from SEC Form 13F filings across 33 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 33 institutions disclosed 491,150 shares of Cue Biopharma, Inc. worth $15.5M — about 7.7% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
33
13F holders
$15.5M
value, 2026 filers
7.7%
of shares outstanding (491,150 sh)
32
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of CUE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 161,700 | $5.1M | 0.0% | 2.6% | new |
| 2 | BlackRock, Inc.NEW | 57,807 | $1.8M | 0.0% | 0.9% | new |
| 3 | DIADEMA PARTNERS LPNEW | 48,369 | $1.5M | 0.2% | 0.8% | new |
| 4 | GEODE CAPITAL MANAGEMENT, LLCNEW | 47,824 | $1.5M | 0.0% | 0.8% | new |
| 5 | BOOTHBAY FUND MANAGEMENT, LLCNEW | 31,459 | $992,846 | 0.0% | 0.5% | new |
| 6 | UBS Group AGNEW | 26,700 | $842,652 | 0.0% | 0.4% | new |
| 7 | CITADEL ADVISORS LLCNEW | 25,633 | $808,977 | 0.0% | 0.4% | new |
| 8 | VANGUARD FIDUCIARY TRUST CONEW | 24,476 | $772,463 | 0.0% | 0.4% | new |
| 9 | Persistent Asset Partners LtdNEW | 12,332 | $389,198 | 0.1% | 0.2% | new |
| 10 | Robertson Stephens Wealth Management, LLCNEW | 11,133 | $351,357 | 0.0% | 0.2% | new |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 11,003 | $347,255 | 0.0% | 0.2% | new |
| 12 | NORTHERN TRUST CORPNEW | 9,122 | $287,890 | 0.0% | 0.1% | new |
| 13 | STIFEL FINANCIAL CORPNEW | 8,218 | $259,360 | 0.0% | 0.1% | new |
| 14 | BANK OF AMERICA CORP /DE/NEW | 6,929 | $218,680 | 0.0% | 0.1% | new |
| 15 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CONEW | 2,632 | $83,066 | 0.0% | 0% | new |
| 16 | Vanguard Global Advisers, LLCNEW | 1,637 | $51,664 | 0.0% | 0% | new |
| 17 | BNP PARIBAS FINANCIAL MARKETSNEW | 1,117 | $35,253 | 0.0% | 0% | new |
| 18 | Tower Research Capital LLC (TRC)NEW | 869 | $27,426 | 0.0% | 0% | new |
| 19 | MORGAN STANLEYNEW | 674 | $21,271 | 0.0% | 0% | new |
| 20 | BARCLAYS PLCNEW | 479 | $15,117 | 0.0% | 0% | new |
| 21 | SBI Securities Co., Ltd.NEW | 300 | $9,468 | 0.0% | 0% | new |
| 22 | JONES FINANCIAL COMPANIES LLLPNEW | 213 | $5,408 | 0.0% | 0% | new |
| 23 | JPMORGAN CHASE & CONEW | 163 | $4,960 | 0.0% | 0% | new |
| 24 | NFSG CorpNEW | 99 | $3,124 | 0.0% | 0% | new |
| 25 | Golden State Wealth Management, LLCNEW | 66 | $2,083 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.